Hints and tips:
Related Special Reports
...The organisation has attracted growing international interest from backers, including donations announced in October of $10mn each from former Google chief executive Eric Schmidt and billionaire investor...
...Global stock market concentration is at its highest level in decades, increasing risk for passive investors....
...What was astonishing though even for longtime Japan watchers was that the competing bid came from one of the largest life insurers which, in common with many other big Japanese institutional investors, was...
...The diagnostics start-up, co-founded by 27-year-old Connor Campbell, who attended but did not finish medical school, has already raised $100mn in the five years since its launch....
...One of its largest investors withdrew not long after....
...is to become one of the top publicly traded growth investors in Europe....
...But the growing involvement of financial investors in a proudly public sector organisation is not without controversy....
...Given the risks, any potential investor must seek advice from a specialist life sciences investment professional who may be able to suggest investable businesses or funds commensurate with the investor’s...
...Job moves Disney’s chief financial officer Christine McCarthy is stepping down to take a family medical leave of absence....
...The bank is now seeking private-investor backing to develop beyond the pilot stage....
...A report that medical authorities are investigating the deaths of two patients during lecanemab’s trials will increase scepticism. For investors, there is merit in backing dementia research....
...A number of Chinese tech names have listed in Zurich, including lithium battery producers Gotion High-Tech and Sunwoda Electronic, medical device maker Lepu Medical Technology Beijing, and hand tool manufacturer...
...Almost a decade later while working as a researcher at the Karolinska Institute — a Swedish medical body — he unearthed another genetic mutation linked to amyloid-beta aggregates called protofibrils, rod-like...
...Mindray Bio-Medical Electronics....
...Chief Executive Sam Bankman-Fried said in investor meetings this week that Alameda owes FTX about $10 billion, people familiar with the matter said....
...Regulatory filings show an entity called Rhombus Kaiser Ltd invested in European funds, including one managed by Bridgepoint....
...Investors are betting that Eisai, a $20bn pharmaceutical company still little known outside of Japan, can succeed where many larger companies have failed....
...A recent Morgan Stanley report noted that investors would need to see “solid evidence for real-world use cases for AI-enabled drug discovery”....
...spun out one of its late-stage prospects — a vaccine candidate targeting norovirus, which is a contagious disease often caught from contaminated food — into a separate company, HilleVax, to attract new investors...
...But they warned that investor expectations are already very high, so that if anything did go wrong, it could hit shares in AstraZeneca. For patients, Enhertu promises time....
...They’ve tidied up their investor list a fair bit recently....
...Catcher said it was “currently in the stage of business transformation” and was diversifying into areas including manufacturing automotive parts and medical technology....
...The new fund, which will lock up investors’ cash for a number of years, will aim to invest in companies that are between about six and 24 months away from going public, in areas such as biotechnology, medical...
...Despite contemplating following his parents in a medical career, Buckley joined Vanguard in 1991 as assistant to founder Jack Bogle. In 2018, he became the company’s third CEO since Bogle’s retirement....
...Paragraf, which was spun out of Cambridge university, has developed graphene materials with the thickness of a single atom that can be applied to a range of medical, electronic and energy devices....
International Edition